Skip to main content
SpringerLink
Log in

Recent advances in multiple myeloma

  • Introduction to Review Articles
  • Published:
International Journal of Clinical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Hideshima T, Mitsiades C, Tonon G et al (2007) Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets. Nat Rev Cancer 7:585–598

    Article  CAS  PubMed  Google Scholar 

  2. Kumar SK, Rajkumar SV, Dispenzieri A et al (2008) Improved survival in multiple myeloma and the impact of novel therapies. Blood 111:2516–2520

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  3. Dimopoulos M, Spencer A, Attal M et al (2009) Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma. N Engl J Med 357:2123–2132

    Article  Google Scholar 

  4. Richardson PG, Sonneveld P, Schuster MW et al (2005) Assessment of proteasome inhibition for extending remissions (APEX) investigators. Bortezomib or high-dose dexamethasone for relapsed multiple myeloma. N Engl J Med 352:2487–2498

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Division of Gastroenterology and Hematology/Oncology, Department on Internal Medicine, Asahikawa Medical University, 2-1, Midorigaoka-Higashi, Asahikawa, Hokkaido, 078-8510, Japan

    Yutaka Kohgo

Authors
  1. Yutaka Kohgo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yutaka Kohgo.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kohgo, Y. Recent advances in multiple myeloma. Int J Clin Oncol 20, 411–412 (2015). https://doi.org/10.1007/s10147-015-0809-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10147-015-0809-4

Keywords

Search

Navigation